WASHINGTON, D.C. – Doctors for America and the Reproductive Health Coalition have filed a new amicus brief in support of FDA’s approval of the use of mifepristone to end pregnancy through ten weeks gestation.
The brief, filed in the U.S. Court of Appeals for the Fifth Circuit, is in response to the decision made last week by Judge Kacsmaryk in the case of Alliance for Hippocratic Medicine vs. U.S. Food and Drug Administration (FDA), in which Judge Kacsmaryk ordered the FDA to stay the approval of mifepristone. Both Doctors for America (DFA) and the Reproductive Health Coalition (RHC) are deeply concerned that the decision made by Judge Kacsmaryk is not based on medical science, nor the robust data available. Mifepristone is a medication that has been safely used by physicians and patients for over 20 years, with research showing that adverse events and outcomes are exceedingly rare, occurring in less than a fraction of 1% of cases.
Doctors for America mobilizes doctors and medical students to be leaders in putting patients over politics on the pressing issues of the day to improve the health of our patients, communities, and nation.
